Email RIS file
Bookmark
Report an Issue

Guidance for industry : influenza, developing drugs for treatment and/or prophylaxis

Additional Titles
Influenza, developing drugs for treatment and/or prophylaxis
Published
Silver Spring, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, [2009]
Physical Description
27 pages : digital, PDF file
Additional Creators
Center for Drug Evaluation and Research (U.S.)
Access Online

Availability

I Want It
I Want It

Finding items...

Restrictions on Access
Free-to-read Unrestricted online access
Report Numbers
HE 20.4702:IN 3/DRAFT
Subject(s)
Note
Title from title screen (viewed on May 5, 2009).
"Draft guidance."
"February 2009."
Bibliography Note
Includes bibliographical references (pages 26-27).
Technical Details
Mode of access: Internet from the CDER web site. Address as of 5/5/09: http://www.fda.gov/cder/guidance/7927dft.pdf; current access available via PURL.
Action Note
committed to retain. Federal Depository Library Program (FDLP). For information on our retention commitment, please contact Microforms and Government Information.
View MARC record | catkey: 5330843